Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...

BTIG analyst Ryan Zimmerman keeps a Neutral rating on Medtronic (MDT) after Centers for Medicare and Medicaid Services ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

The patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.

Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...

Renal denervation could be very effective and helpful for those patients," says Fisher. "But there are 110 to 120 million US patients with hypertension, and close to 75% are not reaching goal.

In recent years, catheter-based radiofrequency denervation of the renal arteries has emerged as a potential treatment for resistant hypertension and is already in clinical use in more than 80 ...

Recall that Medtronic acquired the renal denervation technology from Mountain View, California-based Ardian back in 2010 for $800 million plus milestone payments. Ardian was developing a catheter ...

Editor’s Note: This is part 1 of a two-part Healio Exclusive series on renal denervation for hypertension control. Hypertension remains an outsized burden in the U.S. and globally, affecting one ...